TIMP2 and gastric cancer: Furthermore, Wang and colleagues found that tissue inhibitor of metalloproteinase-2 (TIMP2) could act as a novel candidate biomarker in GC patients using bioinformatics analysis, and they revealed the potential molecular mechanism of TIMP2 in GC malignant progression [11].